Literature DB >> 2821071

Retrovirus-induced feline pure red cell aplasia. Hematopoietic progenitors are infected with feline leukemia virus and erythroid burst-forming cells are uniquely sensitive to heterologous complement.

J L Abkowitz1, R D Holly, C K Grant.   

Abstract

Feline leukemia virus subgroup C/Sarma (FeLV-C) induces pure red cell aplasia (PRCA) in cats. Just before the onset of anemia, erythroid colony-forming cells (CFU-E) become undetectable in marrow culture, yet normal frequencies of erythroid burst-forming cells (BFU-E)- and granulocyte-macrophage colony-forming cells (CFU-GM) persist. To determine if erythroid progenitors were uniquely infected with retrovirus, marrow mononuclear cells from cats viremic with FeLV-C were labeled with monoclonal antibodies to gp70 and then analyzed with a fluorescence-activated cell sorter. Both erythroid and granulocyte-macrophage progenitors were among cells sorting positively, suggesting that infection of BFU-E alone did not result in PRCA. The results were confirmed by complement (C') lysis studies using baby rabbit or guinea pig sera as sources of C'. These studies also suggested that BFU-E from cats with PRCA were unusually sensitive to C' alone, without the addition of antibody. In further studies, we demonstrated that C' activation was via the classical pathway and that C' sensitivity was unique to BFU-E and not a property of CFU-E, CFU-GM, or progenitors that were capable of giving rise to BFU-E in suspension culture. As BFU-E from cats viremic with FeLV-A/Glasgow-1 or the Rickard strain of feline leukemia virus were not sensitive to C', this finding may relate to the pathogenesis of feline PRCA. We hypothesize that, in cats viremic with FeLV-C, the abnormal C' sensitivity of BFU-E leads to the absence of CFU-E and anemia.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2821071      PMCID: PMC442346          DOI: 10.1172/JCI113160

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  35 in total

1.  STUDIES ON DESTRUCTION OF RED BLOOD CELLS. II. CHRONIC HEMOLYTIC ANEMIA WITH PAROXYSMAL NOCTURNAL HEMOGLOBINURIA: CERTAIN IMMUNOLOGICAL ASPECTS OF THE HEMOLYTIC MECHANISM WITH SPECIAL REFERENCE TO SERUM COMPLEMENT.

Authors:  T H Ham; J H Dingle
Journal:  J Clin Invest       Date:  1939-11       Impact factor: 14.808

2.  Erythrocyte acetylcholinesterase deficiency in paroxysmal nocturnal hemoglobinuria (PNH). A comparison of the complement-sensitive and insensitive populations.

Authors:  T R Kunstling; W F Rosse
Journal:  Blood       Date:  1969-04       Impact factor: 22.113

3.  Inactivation of lysis of oncornaviruses by human serum.

Authors:  R M Welsh; F C Jensen; N R Cooper; M B Oldstone
Journal:  Virology       Date:  1976-10-15       Impact factor: 3.616

4.  Introduction of a selectable gene into primitive stem cells capable of long-term reconstitution of the hemopoietic system of W/Wv mice.

Authors:  J E Dick; M C Magli; D Huszar; R A Phillips; A Bernstein
Journal:  Cell       Date:  1985-08       Impact factor: 41.582

5.  The "sugar-water" test for paroxysmal nocturnal hemoglobinuria.

Authors:  R C Hartmann; D E Jenkins
Journal:  N Engl J Med       Date:  1966-07-21       Impact factor: 91.245

6.  Lymphocytes and antibody in retrovirus-induced feline pure red cell aplasia.

Authors:  J L Abkowitz; R L Ott; R D Holly; J W Adamson
Journal:  J Natl Cancer Inst       Date:  1987-01       Impact factor: 13.506

7.  Increased sensitivity to complement of erythroid and myeloid progenitors in paroxysmal nocturnal hemoglobinuria.

Authors:  E N Dessypris; D A Clark; L C McKee; S B Krantz
Journal:  N Engl J Med       Date:  1983-09-22       Impact factor: 91.245

8.  Characterization of the hematopoietic defect in paroxysmal nocturnal hemoglobinuria.

Authors:  J G Moore; R K Humphries; M M Frank; N Young
Journal:  Exp Hematol       Date:  1986-03       Impact factor: 3.084

9.  Direct demonstration of the human parvovirus in erythroid progenitor cells infected in vitro.

Authors:  N Young; M Harrison; J Moore; P Mortimer; R K Humphries
Journal:  J Clin Invest       Date:  1984-12       Impact factor: 14.808

Review 10.  Complement, viruses, and virus-infected cells.

Authors:  N R Cooper; G R Nemerow
Journal:  Springer Semin Immunopathol       Date:  1983
View more
  14 in total

1.  A putative cell surface receptor for anemia-inducing feline leukemia virus subgroup C is a member of a transporter superfamily.

Authors:  C S Tailor; B J Willett; D Kabat
Journal:  J Virol       Date:  1999-08       Impact factor: 5.103

2.  Comprehensive mapping of receptor-functioning domains in feline leukemia virus subgroup C receptor FLVCR1.

Authors:  Jennifer K Brown; Claire Fung; Chetankumar S Tailor
Journal:  J Virol       Date:  2006-02       Impact factor: 5.103

Review 3.  Control of intracellular heme levels: heme transporters and heme oxygenases.

Authors:  Anwar A Khan; John G Quigley
Journal:  Biochim Biophys Acta       Date:  2011-01-14

4.  Does a feline leukemia virus infection pave the way for Bartonella henselae infection in cats?

Authors:  Alexandra U Buchmann; Olivia Kershaw; Volkhard A J Kempf; Achim D Gruber
Journal:  J Clin Microbiol       Date:  2010-07-07       Impact factor: 5.948

5.  Feline Leukemia Virus (FeLV) Disease Outcomes in a Domestic Cat Breeding Colony: Relationship to Endogenous FeLV and Other Chronic Viral Infections.

Authors:  Jordan A Powers; Elliott S Chiu; Simona J Kraberger; Melody Roelke-Parker; Isabella Lowery; Katelyn Erbeck; Ryan Troyer; Scott Carver; Sue VandeWoude
Journal:  J Virol       Date:  2018-08-29       Impact factor: 5.103

6.  An all-feline retroviral packaging system for transduction of human cells.

Authors:  Raymond T Doty; Kathleen M Sabo; Jing Chen; A Dusty Miller; Janis L Abkowitz
Journal:  Hum Gene Ther       Date:  2010-08       Impact factor: 5.695

7.  Hematopoietic target cells of anemogenic subgroup C versus nonanemogenic subgroup A feline leukemia virus.

Authors:  G A Dean; P M Groshek; J I Mullins; E A Hoover
Journal:  J Virol       Date:  1992-09       Impact factor: 5.103

8.  Feline leukemia virus subgroup C phenotype evolves through distinct alterations near the N terminus of the envelope surface glycoprotein.

Authors:  J Brojatsch; B S Kristal; G A Viglianti; R Khiroya; E A Hoover; J I Mullins
Journal:  Proc Natl Acad Sci U S A       Date:  1992-09-15       Impact factor: 11.205

Review 9.  Heme and FLVCR-related transporter families SLC48 and SLC49.

Authors:  Anwar A Khan; John G Quigley
Journal:  Mol Aspects Med       Date:  2013 Apr-Jun

10.  Identification of a feline leukemia virus variant that can use THTR1, FLVCR1, and FLVCR2 for infection.

Authors:  Zvi Shalev; Simon P Duffy; Karen W Adema; Rati Prasad; Naveen Hussain; Brian J Willett; Chetankumar S Tailor
Journal:  J Virol       Date:  2009-04-15       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.